- Home
- GBIO vs NMTC Comparison
GBIO vs NMTC Comparison
Compare GBIO & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- NMTC
- Stock Information
- Founded
- GBIO 2016
- NMTC 2009
- Country
- GBIO United States
- NMTC United States
- Employees
- GBIO N/A
- NMTC N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- GBIO Health Care
- NMTC Health Care
- Exchange
- GBIO Nasdaq
- NMTC Nasdaq
- Market Cap
- GBIO 29.2M
- NMTC 30.9M
- IPO Year
- GBIO 2020
- NMTC N/A
- Fundamental
- Price
- GBIO $0.38
- NMTC $0.61
- Analyst Decision
- GBIO Strong Buy
- NMTC Strong Buy
- Analyst Count
- GBIO 4
- NMTC 1
- Target Price
- GBIO $7.33
- NMTC $1.45
- AVG Volume (30 Days)
- GBIO 476.6K
- NMTC 269.2K
- Earning Date
- GBIO 05-07-2025
- NMTC 05-13-2025
- Dividend Yield
- GBIO N/A
- NMTC N/A
- EPS Growth
- GBIO N/A
- NMTC N/A
- EPS
- GBIO N/A
- NMTC N/A
- Revenue
- GBIO $24,556,000.00
- NMTC $5,758,777.00
- Revenue This Year
- GBIO N/A
- NMTC $292.88
- Revenue Next Year
- GBIO N/A
- NMTC N/A
- P/E Ratio
- GBIO N/A
- NMTC N/A
- Revenue Growth
- GBIO 146.47
- NMTC 54.53
- 52 Week Low
- GBIO $0.32
- NMTC $0.40
- 52 Week High
- GBIO $3.65
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- GBIO 45.45
- NMTC 44.39
- Support Level
- GBIO $0.37
- NMTC $0.59
- Resistance Level
- GBIO $0.41
- NMTC $0.66
- Average True Range (ATR)
- GBIO 0.03
- NMTC 0.05
- MACD
- GBIO 0.00
- NMTC 0.00
- Stochastic Oscillator
- GBIO 28.93
- NMTC 22.66
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.